126 related articles for article (PubMed ID: 2574729)
1. The efficacy and safety of dilevalol in patients with chronic stable angina pectoris.
Glasser SP; Bittar N; Kinhal V; Bennett WT; Koehn DK
J Clin Pharmacol; 1989 Nov; 29(11):983-8. PubMed ID: 2574729
[TBL] [Abstract][Full Text] [Related]
2. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
3. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
Thadani U; Ezekowitz M; Fenney L; Chiang YK
Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
[TBL] [Abstract][Full Text] [Related]
5. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
[TBL] [Abstract][Full Text] [Related]
6. Effects of combined alpha and beta adrenoceptor blockade in patients with angina pectoris. A double blind study comparing labetalol with placebo.
Quyyumi AA; Wright C; Mockus L; Shackell M; Sutton GC; Fox KM
Br Heart J; 1985 Jan; 53(1):47-52. PubMed ID: 3881105
[TBL] [Abstract][Full Text] [Related]
7. Randomised, double-blind, three-way cross-over study of dilevalol 200 and 400 mg and atenolol 100 mg once-daily in patients with chronic stable angina pectoris.
Bowles MJ; Smith L; Glover DR
J Hum Hypertens; 1990 Jun; 4 Suppl 2():85-90. PubMed ID: 2196372
[TBL] [Abstract][Full Text] [Related]
8. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of the addition of nifedipine in patients with mixed angina compared to patients with classic exertional angina: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
Stone PH; Ware JH; DeWood MA; Gore JM; Eich RH; Pietro DA; Parisi AF; Nesto RW; Boden WE; Sharma SC
Am Heart J; 1988 Oct; 116(4):961-71. PubMed ID: 2902779
[TBL] [Abstract][Full Text] [Related]
10. Duration of effects of isradipine during twice daily therapy in angina pectoris.
Thadani U; Chrysant S; Gorwit J; Giles T; Archer S; Iteld B; Singh S; Copen D; Wakeford C; Hobbs S
Cardiovasc Drugs Ther; 1994 Apr; 8(2):199-210. PubMed ID: 7918132
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study.
Boden WE; Bough EW; Reichman MJ; Rich VB; Young PM; Korr KS; Shulman RS
Circulation; 1985 Jun; 71(6):1197-205. PubMed ID: 2859931
[TBL] [Abstract][Full Text] [Related]
12. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
Sellier P; Broustet JP
Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
[TBL] [Abstract][Full Text] [Related]
13. Antianginal and anti-ischemic effects of mibefradil in the treatment of patients with chronic stable angina pectoris.
Alpert JS; Bakx AL; Braun S; Frishman WH; Schneeweiss A; Tzivoni D; Kobrin I
Am J Cardiol; 1997 Aug; 80(4B):20C-26C. PubMed ID: 9286850
[TBL] [Abstract][Full Text] [Related]
14. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.
Stone PH; Gibson RS; Glasser SP; DeWood MA; Parker JD; Kawanishi DT; Crawford MH; Messineo FC; Shook TL; Raby K
Circulation; 1990 Dec; 82(6):1962-72. PubMed ID: 2122926
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris.
Glasser SP; Gana TJ; Pascual LG; Albert KS
Am Heart J; 2005 Feb; 149(2):e1-9. PubMed ID: 15846251
[TBL] [Abstract][Full Text] [Related]
16. Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris. The Angina and Silent Ischemia Study Group (ASIS).
Borzak S; Fenton T; Glasser SP; Shook TL; MacCallum G; Young PM; Stone PH
J Am Coll Cardiol; 1993 Jun; 21(7):1605-11. PubMed ID: 8496526
[TBL] [Abstract][Full Text] [Related]
17. Antianginal and anti-ischaemic efficacy of tedisamil, a potassium channel blocker.
Fox KM; Henderson JR; Kaski JC; Sachse A; Kuester L; Wonnacott S
Heart; 2000 Feb; 83(2):167-71. PubMed ID: 10648489
[TBL] [Abstract][Full Text] [Related]
18. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study.
Ulvenstam G; Diderholm E; Frithz G; Gudbrandsson T; Hedbäck B; Höglund C; Moelstad P; Perk J; Sverrisson JT
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S67-73. PubMed ID: 1282179
[TBL] [Abstract][Full Text] [Related]
19. Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.
Frishman W; Charlap S; Kimmel B; Teicher M; Cinnamon J; Allen L; Strom J
Circulation; 1988 Apr; 77(4):774-86. PubMed ID: 3280158
[TBL] [Abstract][Full Text] [Related]
20. Labetalol in the treatment of stable exertional angina pectoris: a comparison with nifedipine.
Crake T; Mulcahy D; Wright C; Fox K
Eur Heart J; 1988 Nov; 9(11):1200-5. PubMed ID: 3069466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
